Re:The high-stakes race to engineer new psychedelic drugs
by NickC25 on Tuesday August 02, 2022 @02:11PM
(#32322297)
Perhaps.
The whole point of the article is that psychedelics increase neuroplasticity within the brain, and that pharma companies are trying to synthesize a molecule that does exactly that, but without the hallucinations.
The whole point of the article is that psychedelics increase neuroplasticity within the brain, and that pharma companies are trying to synthesize a molecule that does exactly that, but without the hallucinations.
Here's the article in question - perhaps there's something I missed that you might understand better than I do: https://www.nytimes.com/2022/07/15/opinion/hallucinations-ps...